REFERENCES
M. Wachsman, B. G. Petty, K. C. Cundy, H. S. Jaffe, P. E. Fisher, A. Pastelak, and P. S. Lietman. Pharmacokinetics, safety and bioavailability of HPMPC (Cidofovir) in human immunodeficiency virus-infected subjects. Antiviral Res. 29:153-161 (1996).
M. J. M. Hitchcock, H. S. Jaffe, J. C. Martin, and R. J. Stagg. Review—Antiviral portrait series. Cidofovir, a new agent with potent anti-herpesvirus activity. Antiviral Chem. & Chemother. 7:115-127 (1996).
M. N. Arimilli, C. U. Kim, J. Dougherty, A. Mulato, R. Oliyai, J. P. Shaw, K. C. Cundy, and N. Bischofberger. Synthesis, in vitro biological evaluation and oral bioavailability of 9-((R)-2 (phosphonomethoxy)propyl)adenine (PMPA) prodrugs. Antiviral Chem. & Chemother. 8:557-564 (1997).
J-P Shaw, C. M. Sueoka, R. Oliyai, W. A. Lee, M. N. Arimilli, C. U. Kim, and K. C. Cundy. Metabolism and pharmacokinetics of novel oral prodrugs of 9-((R)-2-(phosphonomethoxy)propyl)adenine (PMPA) in dogs. Pharm. Res. 14:1824-1829 (1997).
M. N. Arimmili, K. C. Cundy, J. P. Dougherty, C. U. Kim, R. Oliyai, and V. J. Stella. Antiviral phosphonomethoxy nucleotides analogs having increased oral bioavailability. U.S. Patent 5,977,089 (1999).
M. Safadi, R. Oliyai, and V. J. Stella. Phosphoryloxymethyl carbamates and carbonates—Novel water soluble prodrugs of amines and hindered alcohols. Pharm. Res. 10:1350-1355 (1993).
J. Alexander, R. Cargill, S. R. Michelson, and H. Schwam. (Acyloxy)alkyl carbamates as novel bioreversible prodrugs for amines: Increased permeation through biological membranes. J. Med. Chem. 31:318-322 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yuan, LC., Dahl, T.C. & Oliyai, R. Degradation Kinetics of Oxycarbonyloxymethyl Prodrugs of Phosphonates in Solution. Pharm Res 18, 234–237 (2001). https://doi.org/10.1023/A:1011044804823
Issue Date:
DOI: https://doi.org/10.1023/A:1011044804823